Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 26 maj 2024 · Medicamentous treatment options for fibroids are restricted, and available medications are generally used for short-term treatment of fibroid-induced bleeding. Progestogens and COCs provide a brief symptom improvement but do not reduce fibroid size.

  2. 31 mar 2014 · To compare one-year all-cause and uterine fibroid (UF)-related direct costs in patients treated with one of the following three uterine-sparing procedures: magnetic resonance-guided focused ultrasound (MRgFUS), uterine artery embolization (UAE) and myomectomy.

  3. 13 lut 2018 · Although curative treatment of this tumor relies on surgical therapies, medical treatments are considered the first-line treatment to preserve fertility and avoid or delay surgery. The aim of this review is to provide available and emerging medical treatment options for symptomatic uterine fibroids.

  4. 5 wrz 2017 · To date, therapeutic options for long-term treatment of uterine fibroids (UFs) have been very limited, with surgery being the main medical treatment for >100 years, with large recurrences of tumors.

  5. 17 sie 2016 · Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization. Cardiovasc Intervent Radiol 2007 ;30(1):54–58. Medline Google Scholar

  6. 17 mar 2021 · With the Sonata system, TFA is an effective single‐stage treatment option for non‐pedunculated submucous myomata, and larger or deeper uterine fibroids (including fibroid clusters) for which hysteroscopic treatment is not suitable. ClinicalTrials.gov: FAST‐EU, NCT01226290; SONATA, NCT02228174.

  7. 1 sie 2015 · The total costs, sum of direct and indirect costs, ranged from $11,71725,023 per patient per year, after diagnosis or surgery among patients with uterine fibroid tumors. Compared with control subjects, the additional annual cost ranged from $2200–15,952 per patient.

  1. Ludzie szukają również